IndraLab

Statements

Multikinase inhibitor decreases the amount of CYLD. 2 / 2
| 2
reach
"We have already shown that CYLD expression in HCC cells can be triggered by the multikinase inhibitor sorafenib, by inhibition of Raf-1, as well as by blockage of the pro survival kinases MEK and EGFR and identified the recovery of CYLD expression as an interesting approach for overcoming HCC resistance XREF_BIBR."
25329885
reach
"Finally, we found that CYLD expression was triggered by the multikinase inhibitor, sorafenib, by the inhibition of Raf-1, as well as by the blockage of the pro survival kinases, MEK (U0126) and the epidermal growth factor receptor (AG1478)."
21109933